Cargando…
Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis
OBJECTIVES: In healthcare systems, practices and products of unproven value and cost-effectiveness can decrease value and increase waste. Using the management of complex wounds, this study investigates temporal trends in the use of antimicrobials dressings, places this in the context of available ev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756320/ https://www.ncbi.nlm.nih.gov/pubmed/31530595 http://dx.doi.org/10.1136/bmjopen-2018-028727 |
_version_ | 1783453374313660416 |
---|---|
author | Hussey, Louise Stocks, Susan J Wilson, Paul Dumville, Jo C Cullum, Nicky |
author_facet | Hussey, Louise Stocks, Susan J Wilson, Paul Dumville, Jo C Cullum, Nicky |
author_sort | Hussey, Louise |
collection | PubMed |
description | OBJECTIVES: In healthcare systems, practices and products of unproven value and cost-effectiveness can decrease value and increase waste. Using the management of complex wounds, this study investigates temporal trends in the use of antimicrobials dressings, places this in the context of available evidence and discusses the potential impacts on the UK National Health Service (NHS). DESIGN: Secondary descriptive and interrupted time series (ITS) analysis of NHS prescription data. SETTING: Prescribing Cost Analysis (PCA) details all NHS prescriptions dispensed in the community in England. INTERVENTIONS: An ITS design was used to compare annual changes in the expenditure and use of antimicrobial and non-antimicrobial dressings before and after the publication of the ‘intervention’ of key evidence-based Scottish Intercollegiate Guidelines Network (SIGN) guidance in 2010. PRIMARY AND SECONDARY OUTCOME MEASURES: Trends in use and expenditure of antimicrobial dressings in relation to published clinical guidance. RESULTS: There was a large increase in the prescribing of, and expenditure on, antimicrobial wound dressings between 1997 and 2016. In 1997, the total number of dressings prescribed was 5 792 700; increasing to 11 447 102 in 2009 with expenditure increasing from £1 960 386 to £32 841 263. During the year of the SIGN intervention (2010), there was a significant drop in the use of silver but there was no consistent ongoing reduction from 2011 to 2015. CONCLUSIONS: Prescribing data can be used to identify products of unproven benefit, which also impose a significant financial burden. This study quantifies the huge increase in the use of antimicrobial wound dressings over a 20-year period despite the lack of compelling evidence to support their routine use. There is some suggestion, however that the use and expenditure decreased after the publication of key guidance. Routine data can be used to as part of more systematic efforts to increase value and reduce waste in health systems. |
format | Online Article Text |
id | pubmed-6756320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-67563202019-10-07 Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis Hussey, Louise Stocks, Susan J Wilson, Paul Dumville, Jo C Cullum, Nicky BMJ Open Evidence Based Practice OBJECTIVES: In healthcare systems, practices and products of unproven value and cost-effectiveness can decrease value and increase waste. Using the management of complex wounds, this study investigates temporal trends in the use of antimicrobials dressings, places this in the context of available evidence and discusses the potential impacts on the UK National Health Service (NHS). DESIGN: Secondary descriptive and interrupted time series (ITS) analysis of NHS prescription data. SETTING: Prescribing Cost Analysis (PCA) details all NHS prescriptions dispensed in the community in England. INTERVENTIONS: An ITS design was used to compare annual changes in the expenditure and use of antimicrobial and non-antimicrobial dressings before and after the publication of the ‘intervention’ of key evidence-based Scottish Intercollegiate Guidelines Network (SIGN) guidance in 2010. PRIMARY AND SECONDARY OUTCOME MEASURES: Trends in use and expenditure of antimicrobial dressings in relation to published clinical guidance. RESULTS: There was a large increase in the prescribing of, and expenditure on, antimicrobial wound dressings between 1997 and 2016. In 1997, the total number of dressings prescribed was 5 792 700; increasing to 11 447 102 in 2009 with expenditure increasing from £1 960 386 to £32 841 263. During the year of the SIGN intervention (2010), there was a significant drop in the use of silver but there was no consistent ongoing reduction from 2011 to 2015. CONCLUSIONS: Prescribing data can be used to identify products of unproven benefit, which also impose a significant financial burden. This study quantifies the huge increase in the use of antimicrobial wound dressings over a 20-year period despite the lack of compelling evidence to support their routine use. There is some suggestion, however that the use and expenditure decreased after the publication of key guidance. Routine data can be used to as part of more systematic efforts to increase value and reduce waste in health systems. BMJ Publishing Group 2019-09-17 /pmc/articles/PMC6756320/ /pubmed/31530595 http://dx.doi.org/10.1136/bmjopen-2018-028727 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Evidence Based Practice Hussey, Louise Stocks, Susan J Wilson, Paul Dumville, Jo C Cullum, Nicky Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title | Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title_full | Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title_fullStr | Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title_full_unstemmed | Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title_short | Use of antimicrobial dressings in England and the association with published clinical guidance: interrupted time series analysis |
title_sort | use of antimicrobial dressings in england and the association with published clinical guidance: interrupted time series analysis |
topic | Evidence Based Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756320/ https://www.ncbi.nlm.nih.gov/pubmed/31530595 http://dx.doi.org/10.1136/bmjopen-2018-028727 |
work_keys_str_mv | AT husseylouise useofantimicrobialdressingsinenglandandtheassociationwithpublishedclinicalguidanceinterruptedtimeseriesanalysis AT stockssusanj useofantimicrobialdressingsinenglandandtheassociationwithpublishedclinicalguidanceinterruptedtimeseriesanalysis AT wilsonpaul useofantimicrobialdressingsinenglandandtheassociationwithpublishedclinicalguidanceinterruptedtimeseriesanalysis AT dumvillejoc useofantimicrobialdressingsinenglandandtheassociationwithpublishedclinicalguidanceinterruptedtimeseriesanalysis AT cullumnicky useofantimicrobialdressingsinenglandandtheassociationwithpublishedclinicalguidanceinterruptedtimeseriesanalysis |